A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY ORAL REGIMEN OF 5-FLUOROURACIL (5-FU) PLUS ENILURACIL FOR THE TREATMENT OF PATIENTS WITH TAXANE AND ANTHRACYCLINE-RESISTANT ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS

Authors
RIVERA E CHEVLEN E ECKARDT J KENNEDY MJ SAWHNEY R SUTTON L FRYE D HEDRICK J MCGUIRT C LEVIN J HOHNEKER J WHITE R HORTOBAGYI GN
Citation
E. Rivera et al., A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY ORAL REGIMEN OF 5-FLUOROURACIL (5-FU) PLUS ENILURACIL FOR THE TREATMENT OF PATIENTS WITH TAXANE AND ANTHRACYCLINE-RESISTANT ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS, Annals of oncology, 9, 1998, pp. 70-70
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
70 - 70
Database
ISI
SICI code
0923-7534(1998)9:<70:APOSTE>2.0.ZU;2-2